The problem of the spread of drugs in poor countries

The estimate of the World Health Organization, which states that a third of the world population does not have access to vaccines and essential medical care, it is a further result of the exaggerated power of finance and the prevailing globalization. It also calculates that about ten million lives could be saved by improving the availability of resources. The biggest obstacle is made from the exercise of commercial rights related to the intellectual property of drugs. The issue of patents, in fact, impossible to practice local production, in the least developed countries, many medications, including those essential to treat widespread diseases in the poorest countries and causing the deaths of large numbers of human human. For poor countries, the problem is twofold: it is to implant productive infrastructure, which often prohibitively expensive, without being certain of being able then to produce the necessary drugs. The existence of patents on drugs raises ethical issues, which are rejected by the manufacturers; the problem is that medicines are treated as other assets, while their health function also plays an important social, very high, which could justify the exemptions optics, exclusively commercial, which is treated with the marketing and the consequent spread of medicines. Essentially profit drives the sale of drugs, without which it is no form of attenuation principle merely commercial. If, on the one hand, it is understandable that the pharmaceutical companies, want to return to research investments often significant, on the other hand, the social cost of the large number of deaths, but also imposes a purely economic calculation of the cost of non-development related to loss of a large number of lives. Of course this comparison, the purely cynical, must be overcome by the importance of humanitarian reasons, even if it is not to consider the impact of this problem on seemingly unrelated phenomena as mass migration, which do not take place only for natural disasters , famine and poverty, but also to gain access to decent medical care. Once again, the situation of serious economic crisis, which began in 2008, has made its effects felt in less developed countries, where there has been an increase in diseases faster than that recorded in countries with greater income. It is no coincidence that in the 49 countries that are defined as least developed in the world by the United Nations has suffered more than elsewhere the problem connected with the lack of medicines; However, in Europe we have the case greek, where the crisis has produced health situations of emergency, with the return of diseases absent for decades, and even here linked to the impossibility of access to certain medications, often more expensive, more and more bands large population. The issue therefore goes beyond the territories of less developed countries, think also to the problem of health care in the US, and is imposed as emergency increasingly global. A moratorium would therefore be necessary under the guidance of the United Nations, which should consider the creation of funds in return on investments in research of pharmaceutical companies, making heritage of the community patents through which produce the necessary medicines to lower the mortality rate worldwide, for treatable diseases.